Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

MYST2

Introduction

MYST histone acetyltransferase 2, also known as MYST2, is a human gene.[1]

References

References

  1. ↑ “Entrez Gene: MYST2 MYST histone acetyltransferase 2”.
Further reading

Further reading

  • Iizuka M, Stillman B (1999). “Histone acetyltransferase HBO1 interacts with the ORC1 subunit of the human initiator protein”. J. Biol. Chem. 274 (33): 23027–34. PMID 10438470.
  • Sharma M, Zarnegar M, Li X; et al. (2001). “Androgen receptor interacts with a novel MYST protein, HBO1”. J. Biol. Chem. 275 (45): 35200–8. doi:10.1074/jbc.M004838200. PMID 10930412.
  • Burke TW, Cook JG, Asano M, Nevins JR (2001). “Replication factors MCM2 and ORC1 interact with the histone acetyltransferase HBO1”. J. Biol. Chem. 276 (18): 15397–408. doi:10.1074/jbc.M011556200. PMID 11278932.
  • Yanagisawa J, Kitagawa H, Yanagida M; et al. (2002). “Nuclear receptor function requires a TFTC-type histone acetyl transferase complex”. Mol. Cell. 9 (3): 553–62. PMID 11931763.
  • Cervoni N, Detich N, Seo SB; et al. (2002). “The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing”. J. Biol. Chem. 277 (28): 25026–31. doi:10.1074/jbc.M202256200. PMID 11978794.
  • Sharma D, Fondell JD (2002). “Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo”. Proc. Natl. Acad. Sci. U.S.A. 99 (12): 7934–9. doi:10.1073/pnas.122004799. PMID 12034878.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Ota T, Suzuki Y, Nishikawa T; et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
  • Goehler H, Lalowski M, Stelzl U; et al. (2004). “A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington’s disease”. Mol. Cell. 15 (6): 853–65. doi:10.1016/j.molcel.2004.09.016. PMID 15383276.
  • Gerhard DS, Wagner L, Feingold EA; et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
  • Zong H, Li Z, Liu L; et al. (2005). “Cyclin-dependent kinase 11(p58) interacts with HBO1 and enhances its histone acetyltransferase activity”. FEBS Lett. 579 (17): 3579–88. doi:10.1016/j.febslet.2005.05.039. PMID 15963510.
  • Cereseto A, Manganaro L, Gutierrez MI; et al. (2005). “Acetylation of HIV-1 integrase by p300 regulates viral integration”. EMBO J. 24 (17): 3070–81. doi:10.1038/sj.emboj.7600770. PMID 16096645.
  • Stelzl U, Worm U, Lalowski M; et al. (2005). “A human protein-protein interaction network: a resource for annotating the proteome”. Cell. 122 (6): 957–68. doi:10.1016/j.cell.2005.08.029. PMID 16169070.
  • Rual JF, Venkatesan K, Hao T; et al. (2005). “Towards a proteome-scale map of the human protein-protein interaction network”. Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
  • Doyon Y, Cayrou C, Ullah M; et al. (2006). “ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation”. Mol. Cell. 21 (1): 51–64. doi:10.1016/j.molcel.2005.12.007. PMID 16387653.
  • Iizuka M, Matsui T, Takisawa H, Smith MM (2006). “Regulation of replication licensing by acetyltransferase Hbo1”. Mol. Cell. Biol. 26 (3): 1098–108. doi:10.1128/MCB.26.3.1098-1108.2006. PMID 16428461.
  • Georgiakaki M, Chabbert-Buffet N, Dasen B; et al. (2006). “Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription”. Mol. Endocrinol. 20 (9): 2122–40. doi:10.1210/me.2005-0149. PMID 16645042.
  • Beausoleil SA, Villén J, Gerber SA; et al. (2006). “A probability-based approach for high-throughput protein phosphorylation analysis and site localization”. Nat. Biotechnol. 24 (10): 1285–92. doi:10.1038/nbt1240. PMID 16964243.
  • Olsen JV, Blagoev B, Gnad F; et al. (2006). “Global, in vivo, and site-specific phosphorylation dynamics in signaling networks”. Cell. 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.
  • Topper M, Luo Y, Zhadina M; et al. (2007). “Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication”. J. Virol. 81 (6): 3012–7. doi:10.1128/JVI.02257-06. PMID 17182677.

Template:WikiDoc Sources